Sheng-Jun Xiao
Overview
Explore the profile of Sheng-Jun Xiao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin T, Jia J, Luo W, Lin X, Xiao S, Yang J, et al.
J Exp Clin Cancer Res
. 2024 Feb;
43(1):62.
PMID: 38419081
Background: In recent years, the development of adjunctive therapeutic hyperthermia for cancer therapy has received considerable attention. However, the mechanisms underlying hyperthermia resistance are still poorly understood. In this study,...
2.
Lei Y, Shen H, Li Q, Yang S, Xie H, Li X, et al.
Aging (Albany NY)
. 2023 May;
15(10):4391-4410.
PMID: 37219449
B-cell-specific Moloney murine leukemia virus integration site 1 (Bmi-1) is overexpressed in various cancer types. We found that mRNA levels were elevated in nasopharyngeal carcinoma (NPC) cell lines. In immunohistochemical...
3.
Wang L, Xiao S, Kunimoto H, Tokunaga K, Kojima H, Kimura M, et al.
Int J Mol Sci
. 2021 Oct;
22(19).
PMID: 34638866
RBM10 is an RNA-binding protein that regulates alternative splicing (AS). It localizes to the extra-nucleolar nucleoplasm and S1-1 nuclear bodies (NBs) in the nucleus. We investigated the biological significance of...
4.
Xiao D, Fang T, Lei Y, Xiao S, Xia J, Lin T, et al.
Aging (Albany NY)
. 2021 Sep;
13(17):21497-21512.
PMID: 34491904
Esophageal squamous cell carcinoma (ESCC) is a highly malignant gastrointestinal cancer with a high recurrence rate and poor prognosis. Although N-methyladenosine (mA), the most abundant epitranscriptomic modification of mRNAs, has...
5.
Dian M, Li J, Zhang X, Li Z, Zhou Y, Zhou W, et al.
J Cancer
. 2021 Jun;
12(15):4463-4477.
PMID: 34149910
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and has a poor prognosis due to the high incidence of invasion and metastasis-related progression. However, the underlying mechanism...
6.
Hao W, Zhong Q, Pang W, Dian M, Li J, Han L, et al.
J Cancer
. 2020 Aug;
11(17):5106-5117.
PMID: 32742458
MST4 has exhibited functions in regulating cell polarity, Golgi apparatus, cell migration, and cancer. Mechanistically, it affects the activity of p-ERK, Hippo-YAP pathway and autophagy. The aim of this study...
7.
Bian L, Duan J, Zhou C, Shen G, Wang X, Yang Y, et al.
Mol Med Rep
. 2020 May;
22(1):51-56.
PMID: 32377721
MicroRNA (miR)-19b is expressed in various types of tumors and may serve as a potential therapeutic target. The miR‑17‑92 cluster is upregulated in nasopharyngeal carcinoma (NPC) tissues and cells. miR‑19b...
8.
Li J, Lin T, Chen L, Liu Y, Dian M, Hao W, et al.
Int J Med Sci
. 2020 Apr;
17(7):953-964.
PMID: 32308549
MicroRNA-19 (miR-19) is identified as the key oncogenic component of the miR-17-92 cluster. When we explored the functions of the dysregulated miR-19 in lung cancer, microarray-based data unexpectedly demonstrated that...
9.
Lin T, Chen Y, Jia J, Zhou C, Lian M, Wen Y, et al.
Cancer Manag Res
. 2019 Aug;
11:6959-6969.
PMID: 31413636
The correlation of cold-inducible RNA-binding protein (Cirbp) expression with clinicopathological features including patient prognosis in nasopharyngeal carcinoma (NPC) was investigated. The expression of Cirbp in NPC cell lines and tissue...
10.
Ou-Yang L, Xiao S, Liu P, Yi S, Zhang X, Ou-Yang S, et al.
Mol Med Rep
. 2015 Oct;
12(6):8003-9.
PMID: 26461269
Nasopharyngeal carcinoma (NPC) is a highly invasive malignancy with cervical lymphopathy as the initial presentation. Epithelial‑mesenchymal transition (EMT), a process by which epithelial cells lose cell‑cell adhesion and gain migratory...